Home

ProQuest Investments IV, L.P.

CIK 1431818 · last filed 2017-11-29

ProQuest Investments IV, L.P. is a corporate insider who has filed 8 SEC Form 4 insider transactions across 3 companies since 2009. The most recent filing shows the insider sold $34.0M of URGN on Nov 29, 2017. Across all open-market trades the lifetime net is −$69.1M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $50.8M across reported positions.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$50.77M

Companies

3

Total Filings

8

Lifetime Open-Market Net

-$69.13M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
URGN 10%+ Owner 1,242,031 $40.88 $50.77M -$33.99M 1 2017-11-29
EAGLE PHARMACEUTICALS, INC. (EGRX) Delisted 10%+ Owner 6,777 $2.14 $14.5K -$27.28M 2 2017-05-15
ACHILLION PHARMACEUTICALS INC (ACHN) Delisted 10%+ Owner 2,663,854 — — -$7.86M 1 2009-12-18

Recent Filings

8 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2017-11-29 URGN Sell (S) −837,192 -$33.99M EDGAR
2017-05-15 EAGLE PHARMACEUTICALS, INC. (EGRX) Delisted Other (J) −16,429,365 $0 EDGAR
2016-09-30 EAGLE PHARMACEUTICALS, INC. (EGRX) Delisted Sell (S) −389,500 -$27.28M EDGAR
2015-04-24 — Sell (S) −331,568 -$8.89M
2015-04-08 — Sell (S) −29,980 -$801.1K
2015-03-23 — Sell (S) −177,856 -$4.89M
2014-08-01 — — — $0
2009-12-18 ACHILLION PHARMACEUTICALS INC (ACHN) Delisted Sell (S) −2,253,808 -$7.86M EDGAR
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.